WILMINGTON, Del. - The U.S. Food and Drug Administration (FDA) has granted approval to AstraZeneca (NASDAQ:AZN)'s CALQUENCE® ...
AstraZeneca share rose after it that the company has secured permission to import pharmaceutical formulations of new drug for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback